CLSD - Clearside Biomedical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLSD is currently covered by 5 analysts with an average price target of $6.9. This is a potential upside of $5.95 (626.32%) from yesterday's end of day stock price of $0.95.

Clearside Biomedical's activity chart (see below) currently has 46 price targets and 69 ratings on display. The stock rating distribution of CLSD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 6.94% with an average time for these price targets to be met of 101.63 days.

Highest price target for CLSD is $6, Lowest price target is $5, average price target is $5.2.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 06-Mar-2025. First documented stock forecast 15-Aug-2016.

Currently out of the existing stock ratings of CLSD, 21 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$4.99 (494.06%)

24 days ago
(06-Mar-2025)

0/12 (0%)

$5.15 (605.88%)

Buy

$6

$4.99 (494.06%)

24 days ago
(06-Mar-2025)

0/9 (0%)

$5.15 (605.88%)

Buy

$5

$3.99 (395.05%)

$4

9 months 5 days ago
(25-Jun-2024)

0/2 (0%)

$3.75 (300.00%)

Buy

$5

$3.99 (395.05%)

$5

1 years 17 days ago
(13-Mar-2024)

0/5 (0%)

$3.37 (206.75%)

Buy

$4

$2.99 (296.04%)

$19

1 years 17 days ago
(13-Mar-2024)

2/9 (22.22%)

$2.37 (145.40%)

327

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLSD (Clearside Biomedical) average time for price targets to be met?

On average it took 101.63 days on average for the stock forecasts to be realized with a an average price target met ratio 6.94

Which analyst has the current highest performing score on CLSD (Clearside Biomedical) with a proven track record?

LIANA MOUSSATOS

Which analyst has the current lower performing score on CLSD (Clearside Biomedical) with a proven track record?

ANDREAS ARGYRIDES

Which analyst has the most public recommendations on CLSD (Clearside Biomedical)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on CLSD

Which analyst is the currently most bullish on CLSD (Clearside Biomedical)?

Zegbeh Jallah with highest potential upside - $13.99

Which analyst is the currently most reserved on CLSD (Clearside Biomedical)?

Annabel Samimy with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?